As of 2024-10-04, the Intrinsic Value of Helix Biopharma Corp (HBP.TO) is -0.66 CAD. This HBP.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.19 CAD, the upside of Helix Biopharma Corp is -155.71%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-0.66 - -0.66	-0.66	-155.71%
P/E	(0.01) - (0.04)	(0.01)	-101.1%
DDM - Stable	(0.90) - (2.80)	(1.85)	-255.4%
DDM - Multi	(0.32) - (0.78)	(0.45)	-138.2%